Securities code: Honz Pharmaceutical Co.Ltd(300086) securities abbreviation: Honz Pharmaceutical Co.Ltd(300086) Announcement No.: 2022018 Honz Pharmaceutical Co.Ltd(300086)
Special report on the deposit and use of raised funds in 2021
According to the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (CSRC announcement [2012] No. 44) issued by the CSRC and the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange issued by the Shenzhen Stock Exchange The board of directors of Honz Pharmaceutical Co.Ltd(300086) (hereinafter referred to as “the company” or “the company”) prepared a special report on the annual deposit and actual use of raised funds as of December 31, 2021.
1、 Basic information of raised funds
(I) actual time of funds raised
With the approval of zjxk [2010] No. 549 document of China Securities Regulatory Commission, Honz Pharmaceutical Co.Ltd(300086) on May 13, 2010, publicly issued 25 million RMB ordinary shares to the public, with a par value of RMB 1 per share and an issue price of RMB 60. The total amount of funds raised was RMB 15000000000. After deducting the underwriting Commission, issuance handling fee, lawyer’s fee and other issuance expenses of securities companies, the total amount was RMB 5120230000, The net amount of funds actually raised is RMB 144879770000. The above funds were fully paid on May 18, 2010 and verified by the capital verification report “zsiyyz [2010] No. 01020003” issued by ZHONGSHEN International Certified Public Accountants Co., Ltd.
(II) amount used in previous years, amount used in current year and current balance
Time and amount (yuan)
As of December 31, 2020, the balance of raised funds was 7144624737 plus: interest income of the current year was 422205971 minus: amount used in the current year was 286466062; as of December 31, 2021, the balance of raised funds was 7280364646
2、 Management of raised funds
(I) formulation and implementation of raised funds management system
The company has formulated the raised funds management system in accordance with the requirements of laws and regulations such as the measures for the administration of securities issuance by listed companies, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, and the guidelines for the standardized operation of GEM listed companies of Shenzhen Stock Exchange, The company adopts a special account storage system for the raised funds.
(II) signing of special account for raised funds
The company signed the tripartite supervision agreement on raised funds with Haitong Securities Company Limited(600837) and Haikou Branch of Shenzhen Development Bank Co., Ltd. (later renamed Ping An Bank Co.Ltd(000001) Haikou Branch), Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch and Haikou Rural Commercial Bank Co., Ltd. on May 28, 2010, June 1, 2010 and October 15, 2012 respectively.
On December 31, 2015, the company transferred the special fund-raising account from Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch to Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, cancelled the special fund-raising account of Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch, and signed a tripartite supervision agreement on fund-raising with Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch.
On November 27, 2013, the company signed the four party supervision agreement on raised funds with the wholly-owned subsidiary Hainan Kangzhi Biotechnology Co., Ltd. (formerly Hainan Kangzhi Pharmaceutical Marketing Co., Ltd., renamed on September 30, 2019, hereinafter referred to as “Kangzhi biotechnology”), Haitong Securities Company Limited(600837) and Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch; On December 31, 2013, the supplementary agreement to the four party supervision agreement on raised funds was signed.
On December 31, 2015, the company signed the four party supervision agreement on raised funds with Kangzhi biology, Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, transferring the special account for raised funds from Industrial And Commercial Bank Of China Limited(601398) to Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, and canceling the special account for raised funds of Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch.
On March 30, 2015, the company signed the four party supervision agreement on raised funds with its wholly-owned subsidiaries Guangdong Kangda Pharmaceutical Co., Ltd. (hereinafter referred to as “Kangda pharmaceutical”), Haitong Securities Company Limited(600837) and Liede Avenue sub branch of Guangzhou Branch of Guangdong Development Bank Co., Ltd.
On July 20, 2018, the company, Kangda pharmaceutical, Haitong Securities Company Limited(600837) and Guangzhou Branch Liede Avenue sub branch of Guangdong Development Bank Co., Ltd. signed the four party supervision agreement on raised funds (special account for super raised funds of hand, foot and mouth disease project).
On November 21, 2012, the company signed the four party supervision agreement on raising funds with the holding subsidiaries Beijing Shunxin Xiangyun Pharmaceutical Co., Ltd. (hereinafter referred to as “Xiangyun pharmaceutical”), Haitong Securities Company Limited(600837) and Bank Of China Limited(601988) Beijing Shunyi Auto City sub branch.
On December 31, 2015, the company signed the four party supervision agreement on raised funds with Xiangyun pharmaceutical, Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch, transferred the special account for raised funds from Bank Of China Limited(601988) Beijing Shunyi Auto City sub branch to Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch, and transferred all the remaining raised funds to the new raised funds account within the current month, and cancelled the original raised funds account. On July 10, 2017, the wholly-owned subsidiary Zhongshan Hongshi Health Technology Co., Ltd. (hereinafter referred to as “Zhongshan Hongshi”), Haitong Securities Company Limited(600837) and Liede Avenue sub branch of Guangzhou Branch of Guangdong Development Bank Co., Ltd. signed the tripartite supervision agreement on the storage of special account for raised funds.
The contents of the above three-party or four-party regulatory agreements are drafted with reference to the model of Shenzhen Stock Exchange, and there is no significant difference. (III) storage of raised funds in special account
As of December 31, 2021, the balance of the special account for the deposit of raised funds is as follows:
Company name deposit bank account balance (yuan) remarks
11004088765607189145484 current account
Ping An Bank Co.Ltd(000001) Haikou Haidian sub branch regular
11004088765602 0.00
Honz Pharmaceutical Co.Ltd(300086) share demand
Ltd. Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch 4616023030188 Norinco International Cooperation Ltd(000065) 14370751813
4616023030180100843509122.44 current account
Haikou rural commercial bank business department 10070987 China Vanke Co.Ltd(000002) 3811663.88 current account
Hainan Kangzhi biological Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch 4616023030188 Tunghsu Azure Renewable Energy Co.Ltd(000040) 6273.65 current account
Technology Co., Ltd. 4616023030188 North Huajin Chemical Industries Co.Ltd(000059) 552557055606 current account
Guangdong Kangda pharmaceutical Guangdong Development Bank Guangzhou Branch Liede Avenue sub branch 12130151101 Shenzhen Wongtee International Enterprise Co.Ltd(000056) 378395853 current account
Ltd. Guangzhou Branch Liede Avenue sub branch of Guangdong Development Bank 9550880052310043454266178 current account
Beijing Shunxin Xiangyun 11006116201801020051223907971 current account
Pharmaceutical Co., Ltd. Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch
Company 11006116201801 New Hua Du Supercenter Co.Ltd(002264) 5204.84 current account
Zhongshan Hongshi health Guangfa Bank Guangzhou Branch Liede Avenue sub branch current account
Technology Co., Ltd. 9550880267330 Goody Science & Technology Co.Ltd(002694) 7152.60
Total 7280364646
(IV) cash management of raised funds
The fifth meeting of the board of directors on the use of the raised funds (including the raised funds) of the subsidiaries in excess of the raised funds in November 2020 was held on the premise that the proposal on the use of the raised funds in excess of the raised funds (including the raised funds) was not affected by the normal use of the raised funds of the subsidiaries in November 2020, For the purchase of investment products of commercial banks with high security, good liquidity, principal guaranteed commitment and a term of no more than 12 months, the funds can be used on a rolling basis within the above limit, and the management is authorized to handle it in detail.
As of December 31, 2021, the details of the company and its subsidiaries using the raised funds for cash management are shown in the table below:
Unit: 10000 yuan
Whether the related party is responsible for financial remuneration and whether the actual amount in the current period is subject to the trustee’s name relationship, the transaction product type, the starting date and ending date, and the specified principal amount has been recovered in a certain way
Bank of communications Haikou Nanhai no demand structured deposit s 32 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency branch
Bank of communications Haikou Nanhai no demand structured deposit s 23 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency sub branch
Bank of communications Haikou Nanhai no demand structured deposit s fund 11 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency branch
Total 6600
As of December 31, 2021, the balance of the company’s use of raised funds to purchase bank investment and financial products is zero. 3、 Actual use of raised funds
As of December 31, 2021, the company has used a total of 1628690100 yuan of raised funds, including 281576800 yuan of investment projects with raised funds, exceeding
